The role of microRNA-196a in tumorigenesis, tumor progression, and prognosis
- PMID: 27752997
- DOI: 10.1007/s13277-016-5430-2
The role of microRNA-196a in tumorigenesis, tumor progression, and prognosis
Abstract
MicroRNAs are a large group of non-coding RNAs that have emerged as regulators of various biological processes, especially carcinogenesis and cancer progression. Recent evidence has shown that microRNA-196a (miR-196a) is upregulated in most types of tumors and involved in multiple biological processes via translational inhibition and mRNA cleavage, such as cell proliferation, migration, and invasion, mostly functioning as an oncogene. Dysregulation of miR-196a promotes oncogenesis and tumor progression. In this review, we summarize the upstream regulators, target genes, signaling pathways, and single nucleotide polymorphisms of miR-196a, which collectively affect cell proliferation, migration, and invasion. In addition, we review the clinical outcomes and significance of miR-196a. miR-196a may serve as a novel biomarker or target for diagnosis, prognosis, and therapy in several human cancers.
Keywords: Biomarker; MicroRNA-196a; Prognosis; Tumor progression; Tumorigenesis.
Similar articles
-
MicroRNA-196a promotes renal cancer cell migration and invasion by targeting BRAM1 to regulate SMAD and MAPK signaling pathways.Int J Biol Sci. 2021 Oct 17;17(15):4254-4270. doi: 10.7150/ijbs.60805. eCollection 2021. Int J Biol Sci. 2021. PMID: 34803496 Free PMC article.
-
MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5.BMC Cancer. 2012 Aug 9;12:348. doi: 10.1186/1471-2407-12-348. BMC Cancer. 2012. PMID: 22876840 Free PMC article.
-
Downregulation of microRNA-196a inhibits human liver cancer cell proliferation and invasion by targeting FOXO1.Oncol Rep. 2017 Oct;38(4):2148-2154. doi: 10.3892/or.2017.5873. Epub 2017 Aug 3. Oncol Rep. 2017. PMID: 28791406 Free PMC article.
-
miR-196a in the carcinogenesis and other disorders with an especial focus on its biomarker capacity.Pathol Res Pract. 2024 Aug;260:155433. doi: 10.1016/j.prp.2024.155433. Epub 2024 Jun 30. Pathol Res Pract. 2024. PMID: 38959626 Review.
-
Prognostic Value of MicroRNA-196a in Asian Cancer Patients: a Meta-Analysis.Clin Lab. 2016 Nov 1;62(11):2257-2265. doi: 10.7754/Clin.Lab.2016.160425. Clin Lab. 2016. PMID: 28164681 Review.
Cited by
-
MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma.Oncol Lett. 2018 Feb;15(2):2349-2363. doi: 10.3892/ol.2017.7562. Epub 2017 Dec 8. Oncol Lett. 2018. PMID: 29434944 Free PMC article.
-
Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes.Mol Cancer. 2017 Oct 5;16(1):156. doi: 10.1186/s12943-017-0726-4. Mol Cancer. 2017. PMID: 28982366 Free PMC article.
-
Expression of Selected miRNAs in Normal and Cancer-Associated Fibroblasts and in BxPc3 and MIA PaCa-2 Cell Lines of Pancreatic Ductal Adenocarcinoma.Int J Mol Sci. 2023 Feb 10;24(4):3617. doi: 10.3390/ijms24043617. Int J Mol Sci. 2023. PMID: 36835029 Free PMC article.
-
Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer.Oncotarget. 2017 Aug 18;8(44):77028-77040. doi: 10.18632/oncotarget.20332. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100367 Free PMC article.
-
Integrated Interaction Network of MicroRNA Target Genes in Keloid Scarring.Mol Diagn Ther. 2019 Feb;23(1):53-63. doi: 10.1007/s40291-018-0378-0. Mol Diagn Ther. 2019. PMID: 30604399
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources